"CGIE (TM) is being built as future-facing infrastructure rather than a point solution," said Yusuf Henriques, Founder and CEO of IndyGeneUS Bio. "Our objective is to establish the AI×Bio Factory--the ...
IndyGeneUS Bio today announced the filing of a patent application covering its Clinico-Genomic Insight Engine™ ...
A proposed Center for Cannabis Research and Policy could serve as a statewide hub uniting social policy research with ...
NVIDIA and Lilly bring together a world-leading, multidisciplinary team of scientists, AI researchers and engineers to ...
To launch a successful research career in the health sciences, junior faculty need to write persuasive, high-quality grant proposals that get funded ...
Researchers found that rather than washing pathogens away, strong fluid currents act as "guide rails" that align bacteria and accelerate ...
The Little Rock School District's suspension of a career education partnership blindsided the Academies of Central Arkansas, ...
Charles River Laboratories International, Inc. today announced two planned acquisitions of K.F. (Cambodia) Ltd. and PathoQuest SAS; the addition of Dr. Namandjé N. Bumpus as Chief Scientific and ...
From the start of our conversation, I could see how much Parwana Khazi loves what she does. A first-year Ph.D. student in UC ...
UC San Diego researchers report that 79% of participants in the course have received grant funding as a principal ...
Anthropic has launched Claude for Healthcare, a HIPAA-ready AI platform for hospitals and pharmaceutical companies, days ...
Psyence BioMed Approves 2026 Financial Strategy, Board Authorizes Share Buyback on Value Opportunity
Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence BioMed” or the “Company”), a biopharmaceutical company advancing nature-derived psilocybin and ibogaine therapies for unmet mental health needs, today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results